Collapsed lender South Canterbury Finance is still waiting for any payout from more than $18 million advanced to bizarre biotech startup the BioCorp group.
Receivers John Fisk and Jeremy Morley of PricewaterhouseCoopers were appointed to Biocorp (NZ), Biocorp Mc New Zealand, Biogene UK, New
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Matt Nippert
Fri, 02 Dec 2011
Fri, 02 Dec 2011
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
South Canterbury yet to receive a cent from $18m biotech gamble
18106